CClinicalTrials.gg
CompletedNCT06272513ProAct-HNCUpdated Aug 29, 2025

Influencing Factors for Physical Activity in People With Head and Neck Cancer

An observational study in Advanced Head and Neck Squamous Cell Carcinoma, sponsored by Kantonsspital Winterthur KSW. Completed at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-29.

Sponsored by Kantonsspital Winterthur KSW · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
20
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this qualitative study is to explore influencing factors for physical activity (PA) participation in people affected by an advanced head and neck cancer from the perspective of people affected and their significant others.

Individual interviews will be conducted with people affected by head and neck cancer and focus group interviews will be held with significant others of people being affected to answer the following research questions:

  • What capabilities and opportunities for physical activity participation do people with advanced head and neck cancer experience?
  • What motivates people with advanced head and neck cancer to be physically active?
  • What are recommendations and suggestions for a future physical activity promotion intervention?
  • How do significant others view capabilities, opportunities, and motivation for physical activity participation and promotion in people with head and neck cancer?

The interviews will be transcribed verbatim and analysed with a structuring content analysis approach.

Read the detailed description

see attached study protocol

02

Conditions studied

  • Advanced Head and Neck Squamous Cell Carcinoma

Browse trials for

Keywords

  • qualitative research
  • interviews
  • focus groups
  • physical activity
  • health promotion
03

In context

Motor Activity

2,426 studies on the registry are indexed under Motor Activity; 1,161 are open to participants now.

This study's enrollment of 20 is below the median of 100 across 292 observational studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Kantonsspital Winterthur KSW is the lead sponsor of 34 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

individual interview participants: 12 individuals with a diagnosis of a stage III or IV head and neck squamous cell carcinoma, after surgery \& (chemo)radiotherapy

focus group interview participants: 8 significant others (partner, spouse, close familiy member or friend) of individuals with a diagnosis of a stage III or IV head and neck squamous cell carcinoma

Eligibility criteria

Inclusion criteria for people with head and neck cancer:

  • minimal age 18
  • diagnosis of a primary head and neck squamous cell carcinoma within the last 24 months
  • oral, pharyngeal, or laryngeal cancer stage III or IV
  • completed surgery and/or radio(chemo)therapy in curative intent

Exclusion criteria for people with head and neck cancer:

  • not having the physical, mental, and cognitive ability to understand, follow and hold a conversation in (Swiss-)German
  • treatment in palliative intent
  • recurrence of the head and neck tumour (local or distant)

Inclusion criteria for significant others of people with head and neck cancer:

  • minimal age 18
  • being a significant other (partner, spouse, close family member or friend) of an individual with a head and neck cancer with the above-mentioned criteria
  • having the permission of the individual affected by head and neck cancer to talk about their experiences

Exclusion criteria for significant others of people with head and neck cancer:

- not having the physical, mental, and cognitive ability to understand, follow and take part in a group discussion in (Swiss-)German

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
20 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. interview transcripts

    individual interviews and focus group interviews will be transcribed verbatim to be analyzed

    Time frame: March 2024- May 2025

Secondary outcomes

  1. personal information of participants

    characteristics of interview and focus group participants will be collected to be able to describe the study participants, including age, education level, cancer stage, treatment received, activity levels

    Time frame: March 2024- May 2025

07

Study locations

1 site
  • Kantonsspital Winterthur
    Winterthur, Canton of Zurich, Switzerland
08

References and documents

Study documents

  • Study protocol · Mar 28, 2025

Documents are hosted by the registry — open the source record to download them.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06272513
Lead sponsor
Kantonsspital Winterthur KSW
Collaborators
Eastern Switzerland University of Applied Sciences, University of Applied Sciences of Western Switzerland, UMC Utrecht, University of Lausanne, Zurich University of Applied Sciences
Responsible party
Sponsor
First posted
Feb 22, 2024
Start date
Mar 30, 2024
Primary completion
Jul 30, 2025
Completion
Jul 30, 2025
Last update
Aug 29, 2025

Study contacts

Martina Schmocker, MSc
principal investigator · Cantonal Hospital Winterthur, Switzerland

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion